Publicaciones (37) Publicaciones en las que ha participado algún/a investigador/a

2024

  1. Cómo estimar la composición corporal en la enfermedad de Huntington. Estudio transversal y observacional con bioimpedancia de múltiples frecuencias

    Revista de neurologia, Vol. 78, Núm. 1, pp. 17-25

  2. Impact of CYP2D6 and CYP2B6 phenotypes on the response to tramadol in patients with acute post-surgical pain

    Clinical and Translational Science, Vol. 17, Núm. 1

  3. Neurodevelopmental consequences of gestational exposure to particulate matter 10: Ultrasonic vocalizations and gene expression analysis using a bayesian approach

    Environmental Research, Vol. 240

  4. Sociability: Comparing the Effect of Chlorpyrifos with Valproic Acid

    Journal of Autism and Developmental Disorders

2023

  1. 'Effect of CYP2C19 genetic variants on bleeding and major adverse cardiovascular events in a cohort of Arab patients undergoing percutaneous coronary intervention and stent implantation' by Ali et al. - reassess the evidence, shall we?

    Pharmacogenetics and genomics, Vol. 33, Núm. 4, pp. 88-89

  2. Association Between Insulin-Like Growth Factor-1 and Social Cognition in Huntington's Disease

    Movement Disorders Clinical Practice, Vol. 10, Núm. 2, pp. 279-284

  3. Bortezomib Pharmacogenetic Biomarkers for the Treatment of Multiple Myeloma: Review and Future Perspectives

    Journal of Personalized Medicine, Vol. 13, Núm. 4

  4. Environmental exposure to chlorpyrifos during gestation, APOE polymorphism and the risk on autistic-like behaviors

    Environmental Research, Vol. 237

  5. Identification of Transporter Polymorphisms Influencing Metformin Pharmacokinetics in Healthy Volunteers

    Journal of Personalized Medicine, Vol. 13, Núm. 3

  6. Identification of clinical and pharmacogenetic factors influencing metformin response in Type 2 diabetes mellitus

    Pharmacogenomics, Vol. 24, Núm. 12, pp. 651-663

  7. Occupational performance in Huntington’s disease: A cross-sectional study

    British Journal of Occupational Therapy, Vol. 86, Núm. 6, pp. 432-440

  8. Pharmacogenetics in the Treatment of Huntington’s Disease: Review and Future Perspectives

    Journal of Personalized Medicine, Vol. 13, Núm. 3

  9. Uncovering the link between air pollution and neurodevelopmental alterations during pregnancy and early life exposure: A systematic review

    Neuroscience and Biobehavioral Reviews, Vol. 152

  10. “Pharmacogenetics of siponimod: A systematic review” by Díaz-Villamarín et al. – Information is power

    Biomedicine and Pharmacotherapy

2022

  1. Consensus of experts from the Spanish Pharmacogenetics and Pharmacogenomics Society and the Spanish Society of Medical Oncology for the genotyping of DPYD in cancer patients who are candidates for treatment with fluoropyrimidines

    Clinical and Translational Oncology, Vol. 24, Núm. 3, pp. 483-494

  2. Distinct mechanism of action for antitumoral neutral cyclometalated Pt(II)-complexes bearing antifungal imidazolyl-based drugs

    Journal of Inorganic Biochemistry, Vol. 226

  3. Polymorphisms in the oxytocin receptor and their association with apathy and impaired social cognition in Huntington’s disease

    Neurological Sciences, Vol. 43, Núm. 10, pp. 6079-6085

  4. Protocolo para evaluación de la adecuación del simulador PhysioEx en la asignatura de Fisiología Humana

    XIX Foro Internacional sobre la Evaluación de la Calidad de la Investigación y la Educación Superior (FECIES)

  5. Role of Pharmacogenetics in the Treatment of Acute Myeloid Leukemia: Systematic Review and Future Perspectives

    Pharmaceutics, Vol. 14, Núm. 3

  6. Use of Venetoclax in Patients with Relapsed or Refractory Acute Myeloid Leukemia: The PETHEMA Registry Experience

    Cancers, Vol. 14, Núm. 7